Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 473283018 | Galactose microparticles+palmitic acid 2497.5mg/2.5mg granules+diluent | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 1457647013 | Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial (product) | en | Fully specified name | Active | Entire term case insensitive | SNOMED CT core module |
| 1478040014 | Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | en | Synonym | Active | Entire term case insensitive | SNOMED CT core module |
| 46805101000001110 | Galactose 2.49g / Palmitic acid 2.5mg powder and solvent for suspension for injection 2.5g vials | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom Edition module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Is a | Product containing galactose microparticles | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has active ingredient | Galactose | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has active ingredient | Contrast media | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Is a | Product manufactured as parenteral dose form | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has active ingredient | Palmitic acid | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder and solvent for injection suspension | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | VMP prescribing status (attribute) | VMP valid as a prescribable product | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | VMP non-availability indicator | Available | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder for conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder for conventional release suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has specific active ingredient | Galactose | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has specific active ingredient | Palmitic acid | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has dispensed dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Is a | Virtual medicinal product | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Is a | Product containing galactose and palmitic acid | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | VMP non-availability indicator | Not available | false | Inferred relationship | Existential restriction modifier | ||
| Galactose microparticles 2497.5mg/palmitic acid 2.5mg powder and solvent for injection suspension vial | Has manufactured dose form | Powder and solvent for suspension for injection | false | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR